Editor’s Note: Related Tickers: Intuitive Surgical, Inc. (NASDAQ:ISRG), MAKO Surgical Corp. (NASDAQ:MAKO)
Robot maker did not do enough to warn of possible complications during surgery, suit alleges (NJ.com)

Credit: Intuitive Surgical, Inc. (NASDAQ:ISRG)
MAKO Surgical Corporation Deploys BlackBerry Enterprise Service 10 to Manage Mobile Investments (IT Business Net)
BlackBerry today announced that MAKO Surgical Corp. (NASDAQ:MAKO) has chosen BlackBerry Enterprise Service 10 as their single enterprise mobility management (EMM) solution because it provides the highest level of control required to handle all the mobile data requirements and security issues unique to the medical device manufacturing environment. “MAKO Surgical Corp. is committed to the new BlackBerry 10 platform and we’re very impressed with the unique enterprise benefits the platform brings to our organization,” said Ernie Wittyngham, Senior Director of Information Technology at MAKO Surgical Corp. (NASDAQ:MAKO). “Having secure and reliable support provided by BlackBerry makes sense as BlackBerry is a trusted partner and has been for a long time.”
Would you have surgery at hands of robot (CNN)
Shares of Surgical Robots Plunge; Time to Buy? (YCharts)
Investors wondering whether to avoid or to buy shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) and its controversial robots might want to consider certain line items in the company’s quarterly reports. They help illustrate a perhaps underappreciated fact about the company’s business model: that more than 2,200 hospitals already own its da Vinci robotic surgical system, and they need to keep paying Intuitive Surgical, Inc. (NASDAQ:ISRG) millions of dollars every year to ensure that their own massive investments in them pay off. Sales of new da Vinci systems fell off for the first time ever last quarter amid widely published concerns about safety and cost-effectiveness of the systems, in which surgeons use a patient-side console to direct robotic tools to perform the actual surgery.
MAKO Surgical Corp. Price Target Increased to $26.00 by Analysts at Oppenheimer (MAKO) (Zolmax)
MAKO Surgical Corp. (NASDAQ:MAKO) had its price target upped by Oppenheimer from $23.00 to $26.00 in a research note issued to investors on Thursday, Analyst Ratings.Net reports. The firm currently has an overweight rating on the stock. MAKO Surgical Corp. traded down 1.41% on Thursday, hitting $15.40. MAKO Surgical Corp. (NASDAQ:MAKO) has a 1-year low of $10.00 and a 1-year high of $19.62. The stock’s 50-day moving average is currently $12.54. The company’s market cap is $722.8 million.



